Development of Diagnostic Pathway for Teicoplanin Allergy
NCT03210233
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
548
Enrollment
OTHER
Sponsor class
Conditions
Hypersensitivity
Interventions
PROCEDURE:
Blood test, skin testing and challenge testing.
Sponsor
The Leeds Teaching Hospitals NHS Trust